Evidence map›Paper›PMID 31737612›Full record

ArticleFrontiers in chemistry2019

Low-Molecular-Weight Heparin-Functionalized Chitosan-Chondroitin Sulfate Hydrogels for Controlled Release of TGF-β3 and

You-Rong Chen, Zhu-Xing Zhou, Ji-Ying Zhang, Fu-Zhen Yuan, Bing-Bing Xu, Jian Guan, Chao Han, Dong Jiang, Yan-Yu Yang, Jia-Kuo Yu

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

You-Rong ChenKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Zhu-Xing ZhouKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Ji-Ying ZhangKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Fu-Zhen YuanKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Bing-Bing XuKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Jian GuanKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Chao HanKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Dong JiangKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.
Yan-Yu YangBeijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics & Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
Jia-Kuo YuKnee Surgery Department of the Institute of Sports Medicine, Peking University Third Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repair of hyaline cartilage remains a huge challenge in clinic because of the avascular and aneural characteristics and the paucity of endogenous repair cells. Recently, tissue engineering technique, possessing unique capacity of repairing large tissue defects, avoiding donor complications and two-stage invasive surgical procedures, has been developed a promising therapeutic strategy for cartilage injury. In this study, we incorporated low-molecular-weight heparin (LMWH) into carboxymethyl chitosan-oxidized chondroitin sulfate (CMC-OCS) hydrogel for loading transforming growth factor-β3 (TGF-β3) as matrix of peripheral blood mesenchymal stem cells (PB-MSCs) to construct tissue-engineered cartilage. Meanwhile, three control hydrogels with or without LMWH and/or TGF-β3 were also prepared. The gelling time, microstructures, mechanical properties, degradation rate, cytotoxicity, and the release of TGF-β3 of different hydrogels were investigated.

Indexed as

controlled releasehydrogellow-molecular-weight heparinperipheral blood mesenchymal stem celltissue-engineered cartilage

Identifiers

PMID31737612
PMCPMC6839338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.